Board of management
Philippe is a MD, PhD, is an Hepato-Gastroenterologist, graduated from the medical school at the University Paris VII. He received his PhD in Human Molecular Genetics from the University Paris VII. Philippe served at several scientific and medical management positions in Pharmaceutical industry (Solvay Pharma, Hoffmann-LaRoche) and Biotechnology (Genset, ProteaBio). Philippe is the President and the Chief Scientific Officer of Eukarÿs. He is the inventor of several patents, among which those of the C3P3 system.
David, PhD from Ecole Polytechnique, is a molecular immunologist and former researcher at the Institute Pasteur of Paris. David is the co-founder and Executive Vice-President of Cellectis SA, a biotechnology company specialized in genome engineering for the production of CAR-T cells used for the treatment of malignant hematological diseases. David is also the former Vice President of the MEDICEN competitiveness cluster.
Pierre, Ecole des Ponts et Chaussées, is an entrepreneur and historical investor in the company. Pierre held the Presidency of SORIF, the real estate subsidiary of the Vinci Immobilier Group, of which he was the founder. He currently holds the Presidency of IDEVI (Paris). Pierre brings his strong entrepreneurial and negotiating experience with large groups.
Thierry is the attorney at law of Eukarÿs and a historical investor in the company. Thierry is graduated from the University of Paris II Panthéon-Assas, holds a DEA (now Masters) in Business Law, a Master’s Degree in Tax Management, a Master’s Degree in Common Market Law and a diploma from the Institute of Political Studies (Sciences-Po – EcoFi).
Patrice is an succesful entrepreneur, former elected representative of Essonne and historical investor in the company.
Fabrice is graduated from the Paris Institute of Political Studies and in Law from the University of Paris I Panthéon-Sorbonne. Member of SFAF, CEO of Eponyme Partners, director of BodyCap, Fabrice is the President of PPRS, a company specialized in the development of therapeutics, diagnostics and medical devices in the neuroscience field.